US Stocks
/
Lucid Diagnostics Inc. Share Price

Lucid Diagnostics Inc. Share Price

NASDAQ: LUCD | Micro Cap
$0.97
+$0.01 (1.54%) Last updated on 08 Aug, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Lucid Diagnostics Inc. Stock Performance

Open
$0.96
Prev. Close
$0.95
Circuit Range
N/A
Day Range
$0.94 - $0.96
Year Range
$0.86 - $1.62
Volume
4,779
Average Traded
$0.96

Lucid Diagnostics Inc. Share Price Today

As of 10 August 2026, Lucid Diagnostics Inc.'s share price is $0.97. The stock opened at $0.96, compared to its previous close of $0.95. During today's trading session, Lucid Diagnostics Inc.'s share price traded between $0.94 and $0.96, with an average price of $0.95. Over the past 52 weeks, the stock has recorded a high of $1.62 and a low of $0.86. In terms of performance, Lucid Diagnostics Inc.'s share price has declined by 33.30% over the last six months and is down 23.55% on a year-on-year basis.

Lucid Diagnostics Inc. Share Price Chart

$0.94$0.96
L
Show Current Price
H

Lucid Diagnostics Inc. Stock Fundamentals & Key Indicators

Market Cap
$98.59M
PE Ratio (TTM)
-1.40
Dividend Yield
N/A
EPS (TTM)
$-0.69
Revenue (TTM)
$4.71M
Return On Equity (TTM)
-530.45%
Profit Margin
-1232.68%
Debt to Equity
2.61
Quarterly Earnings Growth YoY
15.96%

Lucid Diagnostics Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025
Revenue$1.00M$976000.00$1.17M$828000.00$1.16M$1.21M
Net Profit-$10.61M-$11.01M-$12.37M-$26.91M-$4.44M-$10.40M
Net Profit Margin-1060.14%-1127.56%-1055.55%-3249.76%-381.69%-858.55%
Income ChangeN/A-3.70%-12.41%-117.51%83.50%-134.22%

Lucid Diagnostics Inc. Annual Profit & Loss

All figures in USD

Particulars2021202320242025
Revenue$500000.00$2.43M$4.35M$4.71M
Net Profit-$28.08M-$52.67M-$45.53M-$58.01M
Net Profit Margin-5615.60%-2169.11%-1047.61%-1232.68%
Income ChangeN/A-87.57%13.55%-27.41%

About Lucid Diagnostics Inc.

Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. Its flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths through early detection of esophageal precancer in at-risk GERD patients. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. operates as a subsidiary of PAVmed Inc.

Lucid Diagnostics Inc. Historical Returns

MonthOpenCloseChange %
Aug 2026
$0.90
$0.96
+10.19%
Jul 2026
$1.08
$0.87
-18.03%
Jun 2026
$1.03
$1.06
+3.40%
May 2026
$1.08
$1.03
-3.74%
Apr 2026
$1.16
$1.07
-6.96%
Mar 2026
$1.41
$1.15
-20.69%
Feb 2026
$1.18
$1.45
+22.88%
Jan 2026
$1.08
$1.18
+8.76%
Dec 2025
$1.06
$1.08
+2.36%
Nov 2025
$1.21
$1.06
-11.67%
Oct 2025
$1.01
$1.20
+18.81%
Sep 2025
$1.25
$1.01
-20.16%

LUCD Share Price FAQs

What is Lucid Diagnostics Inc. share price today?

chevron-up
Lucid Diagnostics Inc. share price today is $0.97 as on August 8, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Lucid Diagnostics Inc. stock?

chevron-up
The 52 week high of Lucid Diagnostics Inc. stock is $1.62, while the 52 week low is $0.86 as of 8 Aug '26.

What is LUCD's market capitalisation today?

chevron-up
LUCD market capitalisation is $98.59M as of August 10, 2026, at 10:38 am IST.

What is LUCD's net income for the last quarter?

chevron-up
LUCD's net income for the last quarter is -0.01B USD.

What is the 5 year returns of LUCD?

chevron-up
The 5 year returns of LUCD is -90.30% as on 8 Aug '26.

What is the high & low stock price of LUCD today?

chevron-up
LUCD stock price hit a high of $0.96 and low of $0.94 as of 8 Aug '26.

Can I buy LUCD shares in India?

chevron-up
Yes. You can buy LUCD in India by opening an international trading account.